The placebo response in social phobia

被引:16
|
作者
Oosterbaan, DB
van Balkom, AJLM
Spinhoven, P
van Dyck, R
机构
[1] Vrije Univ Amsterdam, Dept Psychiat, NL-1075 BG Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Inst Res Extramural Med, NL-1075 BG Amsterdam, Netherlands
[3] Leiden Univ, Dept Psychiat, Leiden, Netherlands
[4] Leiden Univ, Div Clin & Hlth Psychol, Leiden, Netherlands
关键词
clinical trial; double-blind method; review; placebo; social anxiety disorder; social phobia;
D O I
10.1177/026988110101500314
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The placebo response forms a growing problem in randomized, placebo-controlled clinical trials in psychiatry. Research into the placebo response is on the increase, but remains very limited in relation to social phobia. Together with the dropout rate, the placebo effect is an important factor limiting the discriminative properties of any study. In this study, we reviewed 15 placebo-controlled studies in social phobia, focussing on patients and study characteristics. In social phobia, the placebo effect has turned out to be moderately large and has shown no increase over the past decade. Placebo response was highest in large, multicentred trials and was independent of study duration. No validation for a placebo run-in was found. Taking into account both response to placebo and active drug, as well as dropout rate, the most discriminative results are probably to be expected in a sample of patients who are moderately to severely impaired. More research in the field of the placebo response is needed.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [1] TREATMENT OF SOCIAL PHOBIA WITH CLONAZEPAM AND PLACEBO
    DAVIDSON, JRT
    POTTS, N
    RICHICHI, E
    KRISHNAN, R
    FORD, SM
    SMITH, R
    WILSON, WH
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1993, 13 (06) : 423 - 428
  • [2] RESPONSE TO ALCOHOL IN SOCIAL PHOBIA
    NAFTOLOWITZ, DF
    VAUGHN, BV
    RANC, J
    TANCER, ME
    [J]. ANXIETY, 1994, 1 (02): : 96 - 99
  • [3] Levetiracetam in social phobia: a placebo controlled pilot study
    Zhang, W
    Connor, KM
    Davidson, JRT
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 551 - 553
  • [4] Placebo-controlled trial of moclobemide in social phobia
    Schneier, FR
    Goetz, D
    Campeas, R
    Fallon, B
    Marshall, R
    Liebowitz, MR
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1998, 172 : 70 - 77
  • [5] SOCIAL PHOBIA, MVP, AND RESPONSE TO IMIPRAMINE
    BENCA, R
    MATUZAS, W
    ALSADIR, J
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1986, 6 (01) : 50 - 51
  • [6] Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder
    Huppert, JD
    Schultz, LT
    Foa, EB
    Barlow, DH
    Davidson, JRT
    Gorman, JM
    Shear, MK
    Simpson, HB
    Woods, SW
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (08): : 1485 - 1487
  • [7] A placebo-controlled study of sertraline in generalized social phobia
    Van Ameringen, M
    Swinson, R
    Walker, JR
    Lane, RM
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 : 383S - 383S
  • [8] Treatment of social phobia with gabapentin: A placebo-controlled study
    Pande, AC
    Davidson, JRT
    Jefferson, JW
    Janney, CA
    Katzelnick, DJ
    Weisler, RH
    Greist, JH
    Sutherland, SM
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (04) : 341 - 348
  • [9] Generalized social Phobia Mirtazapine no more effective than Placebo
    Angersbach, Dieter
    [J]. PSYCHOPHARMAKOTHERAPIE, 2011, 18 (03): : 142 - 143
  • [10] Clinical features and treatment response in social phobia:: axis II comorbidity and social phobia subtypes
    Ruipérez, MA
    García-Palacios, A
    Botella, C
    [J]. PSICOTHEMA, 2002, 14 (02) : 426 - 433